中国国家药品公司否认与被控非法购买人体遗骸的山西-奥斯特奥拉生物材料公司有商业联系。 China National Medicines denies business ties with Shanxi Osteorad Biomaterial Co, accused of purchasing human remains illegally.

Sinopharm的《中国国家医药》否认与Shanxi Osteorad生物材料公司有商业联系,后者被指控非法购买人体遗骸和肢体,用于骨质移植材料生产。 Sinopharm's China National Medicines denies business ties with Shanxi Osteorad Biomaterial Co, accused of purchasing human remains and limbs illegally for bone implantable materials production. 文件报告说,地方当局正在调查涉及数千具被窃尸体的案件。 The Paper reports local authorities are investigating the case involving thousands of bodies stolen. 中国国家药品公司上海证券交易所的申报书指出,与这两家公司有关的媒体报道不正确,业务不受影响。 The Shanghai Stock Exchange filing by China National Medicines states that media reports linking the two are incorrect, and operations remain unaffected.